CONTACT US | Phone: 1-800-537-2790
  • COMPANY
    • OVERVIEW
    • QUALITY
    • CAREERS
  • PRODUCTS
    • RENUVION®
    • J-PLASMA®
    • PATENTS
    • SYMBOL GLOSSARY
    • Electronic IFU Portal
    • Electronic IFU Portal
  • INVESTOR RELATIONS
  • BLOG
  • COMPANY
    • OVERVIEW
    • QUALITY
    • CAREERS
  • PRODUCTS
    • RENUVION®
    • J-PLASMA®
    • PATENTS
    • SYMBOL GLOSSARY
    • Electronic IFU Portal
    • Electronic IFU Portal
  • INVESTOR RELATIONS
  • BLOG

J-Plasma

Home » J-Plasma
By Nick Johnson (Apyx)
In 2025 Shareholder News, J-Plasma, Renuvion
Posted May 8, 2025

APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

READ MORE
By Nick Johnson (Apyx)
In 2025 Shareholder News, J-Plasma, Renuvion
Posted April 24, 2025

APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2025 FINANCIAL RESULTS ON MAY 8, 2025

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, 2025 Shareholder News, J-Plasma, Renuvion
Posted March 13, 2025

APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, 2025 Shareholder News, J-Plasma, Renuvion
Posted February 28, 2025

APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2024 FINANCIAL RESULTS ON MARCH 13, 2025

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, 2025 Shareholder News, J-Plasma, Renuvion
Posted January 13, 2025

APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2024 REVENUE RESULTS

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, J-Plasma, Renuvion
Posted November 8, 2024

APYX MEDICAL CORPORATION ANNOUNCES $7,000,000 MILLION REGISTERED DIRECT OFFERING

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, J-Plasma, Renuvion
Posted November 7, 2024

Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, J-Plasma, Renuvion
Posted October 24, 2024

APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON NOVEMBER 8, 2024

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, J-Plasma, Renuvion
Posted August 8, 2024

APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION COMPARING THE USE OF RENUVION TO A COMPETING TECHNOLOGY FOLLOWING LIPOSUCTION OR BODY CONTOURING PROCEDURES

READ MORE
By Nick Johnson (Apyx)
In 2024 Shareholder News, J-Plasma, Renuvion
Posted August 8, 2024

APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS; UPDATES FULL YEAR 2024 FINANCIAL OUTLOOK

READ MORE
1 2 3 4 5 6 7 8 9 ...
page 1 of 14

© Copyright 2024 Apyx Medical. All rights reserved. Renuvion®, J-Plasma® and Reshaping What's Possible® are registered trademarks of Apyx Medical Corporation. Bovie® is a registered trademark of Symmetry Surgical. Energy Elevating Lives℠ is a service mark of Apyx Medical Corporation. Apyx™ is a trademark of Apyx Medical Corporation.

Contact Us | Privacy Policy | Terms of Use | Disclaimer

Top
This site tracks visits anonymously. Visit our Privacy Policy page to learn more about the data we collect, and the cookies used on this site. If you agree with these policies, click the AGREE button to close this message.

AGREEPrivacy policy